Us Bancorp \De\ Delcath Systems, Inc. Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 250 shares of DCTH stock, worth $4,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250Holding current value
$4,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DCTH
# of Institutions
80Shares Held
7.41MCall Options Held
198KPut Options Held
41.7K-
Aigh Capital Management LLC Baltimore, MD1.78MShares$28.5 Million6.51% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$19.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA997KShares$16 Million1.32% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny312KShares$4.99 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA252KShares$4.03 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $138M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...